Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
non–small cell lung cancer
ASSESS
EGFR Mutations Can Be Analyzed With ctDNA
ESTERN
Neoadjuvant Erlotinib Showed Promise in NSCLC Patients With EGFR Mutations
Veliparib Plus Platinum Therapy Promising in NSCLC Phase 2 Trial
Novel Compound Beneficial as Adjunct to Antibody-Based Therapy for Stage IV NSCLC Patients
ALTER0302
Anlotinib Increased PFS as Third-Line Treatment for Refractory Advanced NSCLC
Platinum-Plus Regimens Equally Effective First Therapies for EGFR Wild-Type NSCLC
The Road to Patient-Based Therapy for NSCLC
ARCHER 1009 Subset Analysis and LUX-8 Lung: Erlotinib Compared With Dacomitinib or Afatinib
